1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant

BACKGROUND: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among immunocompromised patients with hematologic malignancies (HM) and stem cell transplants (SCT). Isavuconazole was approved by FDA as a primary therapy for Invasive Aspergillosis (IA) and Mucormycosis. The...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: dagher, Hiba, Hachem, Ray Y, Chaftari, Anne-Marie, Jiang, Ying, Ali, Shahnoor, Deeba, Rita, Shah, Shivan, Raad, Issam I
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776545/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1368
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares